Health News – Health News – Health.com

An experimental drug improves patients’ blood sugar control without increasing the risk of low blood sugar hypoglycemia in patients with type 2 diabetes, according to the results of a phase 2 clinical trial.Type 2 diabetes is the more prevalent form of the disease, accounting for about 90 percent of cases. Often tied to obesity, type 2 diabetes involves a gradual decline in how insulin responds to changes in blood sugar glucose

Reposted by GentleCare Aston Pa. 19014

This entry was posted in Gentle Care. Bookmark the permalink.

Comments are closed.